Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12

Garris, Christopher S., Arlauckas, Sean P., Kohler, Rainer H., Trefny, Marcel P., Garren, Seth, Piot, Cécile, Engblom, Camilla, Pfirschke, Christina +15 more·2018·Immunity

Cited by (970)

Items 601–700 of 970

  1. New technology on the horizon: Fast analytical screening technique FNA (FAST‐FNA) enables rapid, multiplex biomarker analysis in head and neck cancers
    Sara Isabel Pai, William C. Faquin, Peter M. Sadow, Mikaël J. Pittet, Ralph Weissleder · 2020 · Cancer Cytopathology
  2. Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma
    Anqi Lin, Wentao Xu, Peng Luo, Jian Zhang · 2021 · Frontiers in Pharmacology
  3. Novel Fluorinated Spermine and Small Molecule PEI to Deliver Anti-PD-L1 and Anti-VEGF siRNA for Highly Efficient Tumor Therapy
    Yihui Zhang, Zihan Yuan, Yi Jin, Wenkai Zhang, Weien Yuan · 2021 · Pharmaceutics
  4. Recent Advances in DNA Vaccines against Lung Cancer: A Mini Review
    Ting Lin Huang, Li Liu, Zheng Lv, Kelei Zhao, Qiong Yi, Jing Zhang · 2022 · Vaccines
  5. Endogenous CD83 Expression in CD4+ Conventional T Cells Controls Inflammatory Immune Responses
    Katarina Liedtke, Christina Alter, Anne Günther, Nadine Hövelmeyer, Robert Klopfleisch, Ronald Naumann, Frank Thomas Wunderlich, Jan Buer, Astrid Maria Westendorf, Wiebke Hansen · 2020 · The Journal of Immunology
  6. Oral administration of Bifidobacterium longum and Bifidobacterium infantis ameliorates cefcapene pivoxil-induced attenuation of anti-programmed cell death protein-1 antibody action in mice
    Funayama, Eiji, Hosonuma, Masahiro, Tajima, Kohei, Isobe, Junya, Baba, Yuta, Murayama, Masakazu, Narikawa, Yoichiro, Toyoda, Hitoshi, Tsurui, Toshiaki, Maruyama, Yuki et al. · 2025 · Biomedicine & Pharmacotherapy
  7. The Biology of Immune-Active Cancers and Their Regulatory Mechanisms
    Davide Bedognetti, Alessandra Cesano, Francesco Maria Marincola, Ena Wang · 2020 · Cancer treatment and research
  8. Nanomaterials for Skin Cancer Photoimmunotherapy
    Carlota M. Relvas, Susana Gomes Santos, María José Oliveira, Fernão Domingos Magalhães, Artur M. Pinto · 2023 · Biomedicines
  9. IL-12/IL-23–Independent Function of BATF3-Dependent Dendritic Cells Is Required for Initiation of Disease in a Mouse Model of Vitiligo
    Michael L. Frisoli, Jillian M. Richmond, John E. Harris · 2024 · Journal of Investigative Dermatology
  10. NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent manner
    Jiwei Zhang, Fen Ma, Zhe Li, Yuan Li, Xun Sun, Mingxu Song, Fan Yang, Enjiang Wu, Xiaohui Wei, Zhengtao Wang et al. · 2024 · MedComm
  11. Disulfidptosis-related genes serve as potential prognostic biomarkers and indicate tumor microenvironment characteristics and immunotherapy response in prostate cancer
    Rongbin Zhou, Dingjin Lu, Junhao Mi, Chengbang Wang, Wenhao Lu, Zuheng Wang, Xiao Li, Chunmeng Wei, Huiyong Zhang, Jin Ji et al. · 2024 · Scientific Reports
  12. Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments
    Um‐e‐Kalsoom, Shiqi Wang, Junle Qu, Liwei Liu · 2024 · Cancer Medicine
  13. Inflammatory factors collaboratively link Helicobacter pylori-induced gastritis to gastric cancer
    Mingze Zhang, Ade Su, Houji Song, Siyu Zhang, Yuan Deng, Wutang Jing, Jin Guo, Weipeng Zhan, Yuntao Ma, Ming Hu · 2025 · Frontiers in Immunology
  14. Interaction of intratumoral microbiota with the tumor immune microenvironment and its impact on cancer progression
    Yan Tingting, Zhu Xiaoling, Yu Zhang, Yan Luo, Yang Luo, Shang Xueqin, Tang Shikai · 2025 · Frontiers in Oncology
  15. Systematic Construction and Validation of a Prognostic Model for Hepatocellular Carcinoma Based on Immune-Related Genes
    Jiahao Yu, Shuoyi Ma, Siyuan Tian, Miao Zhang, Xiaopeng Ding, Yansheng Liu, Fangfang Yang, Yinan Hu, Guoyun Xuan, Xinmin Zhou et al. · 2021 · Frontiers in Cell and Developmental Biology
  16. A Novel Ferroptosis-Related LncRNA Pair Prognostic Signature Predicts Immune Landscapes and Treatment Responses for Gastric Cancer Patients
    Jiazheng Li, Renshen Xiang, Wei Song, Jing Wu, Can Kong, Tao Fu · 2022 · Frontiers in Genetics
  17. Acral Melanoma Is Infiltrated with cDC1s and Functional Exhausted CD8 T Cells Similar to the Cutaneous Melanoma of Sun-Exposed Skin
    Saraí G De León-Rodríguez, Cristina Aguilar-Flores, Julián A. Gajón, Alejandra Mantilla, Raquel Gerson-Cwilich, José Fabián Martínez‐Herrera, Benigno E. Rodríguez-Soto, Claudia Teresita Gutiérrez-Quiroz, Vadim Pérez‐Koldenkova, Samira Muñoz-Cruz et al. · 2023 · International Journal of Molecular Sciences
  18. Machine learning-derived identification of tumor-infiltrating immune cell-related signature for improving prognosis and immunotherapy responses in patients with skin cutaneous melanoma
    Shaolong Leng, Gang Nie, Changhong Yi, Yunsheng Xu, Lvya Zhang, Linyu Zhu · 2023 · Cancer Cell International
  19. Fabrication of An Immunostimulatory Supramolecular Nanomedicine for Potent Cancer Chemoimmunotherapy
    Xinyang Yu, Shaolong Qi, Fangfang Cao, Kai Yang, Hongjian Li, Kun Peng, Zhida Liu, Bing Bai, Marija Buljan, Xiaoyuan Shawn Chen et al. · 2023 · JACS Au
  20. Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma
    Florian Hornsteiner, Janine Vierthaler, Helen Strandt, Antonia Resag, Zhe Fu, Markus Außerhofer, Christoph H. Tripp, Sophie Marie Dieckmann, Markus Kanduth, Kathryn J. Farrand et al. · 2024 · Journal for ImmunoTherapy of Cancer
  21. Protein tyrosine phosphatases: emerging role in cancer therapy resistance
    Min Zhao, Wen Shuai, Zehao Su, Ping Xu, Aoxue Wang, Qiu Sun, Guan Wang · 2024 · 癌症:英文版
  22. Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade
    Seyed Mohammad Miri, Mir Saeed Ebrahimzadeh, Elahe Abdolalipour, Mahsa Yazdi, Hassan Hosseini Ravandi, Amir Ghaemi · 2020 · Cancer Cell International
  23. Identification of Subtypes and a Prognostic Gene Signature in Colon Cancer Using Cell Differentiation Trajectories
    Renshen Xiang, Jincheng Fu, Yuhang Ge, Jun Tao Ren, Wei Song, Tao Fu · 2021 · Frontiers in Cell and Developmental Biology
  24. The soldiers needed to be awakened: Tumor-infiltrating immune cells
    Wang Yaping, Zhe Wang, Chu Zhuling, Ruolei Li, Fan Pengyu, Guo Lili, Ji Cheng, Zhang Bo, Liuyin Liu, Hou Guangdong et al. · 2022 · Frontiers in Genetics
  25. Current “state of the art” on dendritic cell-based cancer vaccines in melanoma
    Julia Katharina Schwarze, Xenia Geeraerts, Sandra Tuyaerts, Bart Neyns · 2023 · Current Opinion in Oncology
  26. Opportunities for improving cancer treatment using systems biology
    Jason I. Griffiths, Adam Louis Cohen, Veronica Jones, Ravi Salgia, Jeffrey T. Chang, Andrea H. Bild · 2019 · Current Opinion in Systems Biology
  27. Cellular Plasticity during Metastasis: New Insights Provided by Intravital Microscopy
    Andreia S. Margarido, Laura Bornes, Claire Vennin, Jacco van Rheenen · 2019 · Cold Spring Harbor Perspectives in Medicine
  28. Host-functionalization of macrin nanoparticles to enable drug loading and control tumor-associated macrophage phenotype
    Biplab Sarkar, Sean P. Arlauckas, Michael F. Cuccarese, Christopher Garris, Ralph Weissleder, Christopher B. Rodell · 2024 · Frontiers in Immunology
  29. DC subsets and states unraveled across human juxtatumoral and malignant tissues
    Kevin Mulder, Margaux Gardet, Wan Ting Kong, Amit Ashok Patel, Anne Calvez, Grégoire Gessain, Carlos de la Calle‐Fabregat, Cécile Piot, Quentin Blampey, Elisa Poupaud et al. · 2025 · Nature Immunology
  30. Comprehensive Analysis of PDLIM3 Expression Profile, Prognostic Value, and Correlations with Immune Infiltrates in Gastric Cancer
    Xinpeng Hu, Minfeng Chen, Qiang Ruan, Changzheng Shi, Jinghua Pan, Liangping Luo · 2022 · Journal of Immunology Research
  31. WT1 Pulsed Human CD141+ Dendritic Cell Vaccine Has High Potential in Solid Tumor-Targeted Immunotherapy
    Sungyoon Cho, Seong Mun Jeong, Young Joo Jeon, Sun Ja Yang, Ju Eun Hwang, Byung Moo Yoo, Hyun Soo Kim · 2023 · International Journal of Molecular Sciences
  32. Dendritic cell maturation in the tumor microenvironment
    Yuhui Miao, Yuning Liu, Haidong Tang, Zemin Zhang · 2023 · National Science Open
  33. Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors
    Jiage Ding, Yanyan Zheng, Fei Zhu, Meng Wang, Lin Fang, Yong U. Liu, Hui Tian, Yong U. Liu, Gang Wang, Junnian Zheng et al. · 2023 · International Immunopharmacology
  34. DNA Damage-driven Inflammatory Cytokines: Reprogramming of Tumor Immune Microenvironment and Application of Oncotherapy
    Mengjie Wang, Xia Yu, Qinglei Gao · 2024 · Current Medical Science
  35. Construction and Validation of an Immune‐Related Gene Prognostic Index for Esophageal Squamous Cell Carcinoma
    Qinghua Ji, Yingying Cai, Sachin Mulmi Shrestha, Duo Shen, Wei Zhao, Ruihua Shi · 2021 · BioMed Research International
  36. Direct and indirect engagement of dendritic cell function by antibodies developed for cancer therapy
    Diana Corogeanu, Sandra S. Diebold · 2022 · Clinical & Experimental Immunology
  37. Cancer Immunotherapy: Diverse Approaches and Obstacles
    Seyed Amir Sanatkar, Arash Heidari, Nima Rezaei · 2022 · Current Pharmaceutical Design
  38. Immune checkpoint inhibitors combined with HER-2 targeted therapy in HER-2 positive gastroesophageal cancer
    Adilai Aisa, Shanshan Weng, Xinyu Li, Ding Zhang, Ying Yuan · 2022 · Critical Reviews in Oncology/Hematology
  39. Transcriptomic analysis of esophageal cancer reveals hub genes and networks involved in cancer progression
    Dipankor Chatterjee, Md. Mostafijur Rahman, Anik Kumar Saha, Mohammad Kawsar Sharif Siam, Mohammad Umer Sharif Shohan · 2023 · Computers in Biology and Medicine
  40. New Clones on the Block
    Nandini Acharya, Ana Carrizosa Anderson · 2019 · Immunity
  41. Teamwork by different T-cell types boosts tumour destruction by immunotherapy
    Jonathan L. Linehan, Lélia Delamarre · 2019 · Nature
  42. Intratumoral mregDC and CXCL13 T helper niches enable local differentiation of CD8 T cells following PD-1 blockade
    A. Magen, P. Hamon, N. Fiaschi, Leanna Troncoso, Étienne Humblin, D. D'Souza, T. Dawson, Matthew D. Park, Joel Kim, Steven Hamel et al. · 2022 · bioRxiv
  43. Advances of oncolytic vaccinia viruses armed with interleukin in tumor therapy
    Mingyong Zha, Fei Huang, Song‐Lin Li, Qi Wang, Yong Tang · 2025 · Frontiers in Oncology
  44. Genetically modified bacterial vesicles with interferon-γ and tumor antigen remodel anti-tumor cellular immunity by modulating dendritic cells
    Yuting Fu, Biao Duan, Peng Zheng, Han Chu, Weiran Li, Ying Yang, Zhongqian Yang, Jinrong He, Mengzhen Wang, Shuqin Li et al. · 2025 · Biomaterials
  45. Arginine Competition in Tumor Microenvironment: A Potential Target for Cancer Therapy
    Junlei Zhang, Sijie Wang, Huihui Liu, Lihua Luo, Jian You · 2025 · Medicinal Research Reviews
  46. Identity, Functions, and the Spatiotemporal Maturation of Type 1 Conventional Dendritic Cells
    Ramazan Akyol, Marc Dalod · 2025 · Immunological Reviews
  47. A clinic-responder-derived defined microbial consortium enhances anti-PD-1 immunotherapy efficacy in mice
    Haiyan Zhou, Ruiming Sun, Xiaoqun Nie, Liliang Xia, Hui Dong, Yujie Liu, Shurui Hou, Wenyue Dong, Xiaokuan Zhu, Yaxian Yao et al. · 2026 · Nature Microbiology
  48. Mathematical modeling identifies LAG3 and HAVCR2 as biomarkers of T cell exhaustion in melanoma
    Richard J. Beck, Sander Sloot, Hirokazu Matsushita, Kazuhiro Kakimi, Joost B. Beltman · 2023 · iScience
  49. Allogeneic NK cells induce the in vitro activation of monocyte-derived and conventional type-2 dendritic cells and trigger an inflammatory response under cancer-associated conditions
    Elisa C. Toffoli, A.A. van Vliet, C Forbes, Annemijn J. Arns, Henk M.W. Verheul, Jurriaan B. Tuynman, Hans J. van der Vliet, Jan Spanholtz, Tanja D. de Gruijl · 2024 · Clinical & Experimental Immunology
  50. Effector Functions of Dendritic Cells in Cancer: Role of Cytotoxicity and Growth Inhibition
    Pratima Chaudhary, Prateek Srivastava, Partha Pratim Manna · 2024 · Frontiers in Bioscience-Landmark
  51. Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Chemotherapy for Advanced Pancreatic Cancer
    Dong Song, Xuejing Yang, Xin Guo, Hu Sun · 2022 · Immunotherapy
  52. Inhibition of Microsomal Prostaglandin E2 Synthase Reduces Collagen Deposition in Melanoma Tumors and May Improve Immunotherapy Efficacy by Reducing T-cell Exhaustion
    Yasunari Fukuda, Sun-Hee Kim, Matias Alberto Bustos, Sung-Nam Cho, Jason Roszik, Jared K. Burks, Hong Kim, Dave S.�B. Hoon, Elizabeth Ann Grimm, Sühendan Ekmekçioglu · 2023 · Cancer Research Communications
  53. Virus‐Like Nanotherapeutic for Spatiotemporally Enhancing Antigen Presentation and Cross‐Presentation toward Potential Personalized Immunotherapy
    Xiaodi Li, Pengfei Yuan, Haiyuan Yang, Xiaoqing Zong, Caiqi Yang, Xinjie Chen, Yuchao Li, Xiaodie Yan, Yaoqi Wen, Tianci Zhu et al. · 2023 · Advanced Healthcare Materials
  54. Combination Immunotherapy Strategies in Breast Cancer
    Brie Chun, David B. Page, Heather L. McArthur · 2019 · Current Breast Cancer Reports
  55. AXL limits the mobilization of cholesterol to regulate dendritic cell maturation and the immunogenic response to cancer
    Meriem Belabed, Matthew D. Park, Cédric M. Blouin, Sreekumar Balan, Chang Yoon Moon, Jesse Boumelha, Ante Peros, Raphaël Mattiuz, Amanda M. Reid, Camillia S. Azimi et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Synergistic effects of Smac mimetic APG-1387 with anti-PD-1 antibody are attributed to increased CD3 + NK1.1 + cell recruitment secondary to induction of cytokines from tumor cells
    Wentao Pan, Qiuyun Luo, Eric Liang, Mude Shi, Jian Sun, Huimin Shen, Zhenhai Lu, Lin Zhang, Xianglei Yan, Luping Yuan et al. · 2024 · Cancer Cell International
  57. Predictive value of dendritic cell-related genes for prognosis and immunotherapy response in lung adenocarcinoma
    Zihao Sun, Mingdao Hu, Xiaoning Huang, Minghan Song, Xiujing Chen, Jiaxin Bei, Yiguang Lin, Size Chen · 2025 · Cancer Cell International
  58. Rejuvenation of Tumor‐Specific T Cells via Ultrahigh DAR Antibody‐Polymeric Imidazoquinoline Complexes: Coordinated Targeting of PDL1 and Efficient TLR7/8 Activation in Intratumoral Dendritic Cells
    Hongyu Chu, Yuezhan Shan, Zongyu Liu, Mengmeng Sun, Weidong Zhao, Xiao Xie, Kun Wang, Chenguang Yang, Xuedong Fang, Na Shen et al. · 2025 · Advanced Materials
  59. Sono-Destructive Polymeric Nanocapsules Enable Spatiotemporal Orchestration of DC-T Cell Crosstalk in Combined In Situ Vaccination and Cytokine Therapy
    Wencong Jia, Wei Yang, Ye Wu, Hongze Ren, Yiwen Jia, Weifan Ye, Yujie Xie, Yu Chen, Meihua Yu · 2025 · Journal of the American Chemical Society
  60. PD-L1 directed bispecific Vδ2-T cell engager combines lysis of PD-L1 expressing tumor cells with PD-1 immune checkpoint inhibition and modulation of the tumor immune microenvironment
    Lisa A. King, Myrthe Veth, Marieke Roos, George L. Scheffer, Marko A. Popovic, Tanja D. de Gruijl, Hans J. van der Vliet · 2025 · Journal for ImmunoTherapy of Cancer
  61. Intratumoral delivery of FLT3L with CXCR3/CCR5 ligands promotes XCR1+ cDC1 infiltration and activates anti-tumor immunity
    Louise Gorline, Fillipe Luiz Rosa Do Carmo, Pierre Bourdely, Jérémie Bornères, Nathan Vaudiau, Aurélie Semervil, Mathias Vétillard, Aboubacar Sidiki K. Coulibaly, Natacha Jugniot, Agathe Ok et al. · 2025 · Nature Communications
  62. Tumor-Intrinsic Nuclear β-Catenin Associates with an Immune Ignorance Phenotype and a Poorer Prognosis in Head and Neck Squamous Cell Carcinomas
    Mario Sánchez‐Canteli, Luis Juesas Iglesias, Irati Garmendia, María Otero‐Rosales, Alfonso Calvo, Mónica Álvarez‐Fernández, Aurora Astudillo, Luis M. Montuenga, Juana Maria Garcia-Pedrero, Juan Pablo Rodrigo · 2022 · International Journal of Molecular Sciences
  63. Epstein-Barr virus DNA seropositivity links distinct tumoral heterogeneity and immune landscape in nasopharyngeal carcinoma
    Wang‐Zhong Li, Shu‐Hui Lv, Guoying Liu, Nian Lu, Yaofei Jiang, Liang Hu, Wei‐Xiong Xia, Yan‐Qun Xiang, Changqing Xie, Jianxing He · 2023 · Frontiers in Immunology
  64. Calcium electroporation of esophageal cancer induces gene expression changes: a sub-study of a phase I clinical trial
    Charlotte Egeland, Lukas Balsevicius, Ismail Gögenür, Julie Gehl, Lene Bæksgaard, Rajendra Singh Garbyal, Michael Patrick Achiam · 2023 · Journal of Cancer Research and Clinical Oncology
  65. The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancer
    Shuangcui Wang, Guan Zhang, Qian Cui, Yanjie Yang, Dong Wang, Aqing Liu, Ying Xia, Wentao Li, Yunhe Liu, Jianchun Yu · 2023 · Immunity Inflammation and Disease
  66. Injectable thermosensitive microsphere-hydrogel composite system: combined therapy of hepatocellular carcinoma by remodeling tumor immune microenvironment
    Jinghan Liao, Zhihua Wu, Yijie Qiu, Fangqin Xue, Ke Gong, Yi Duan, Chao Xu, Bin Liu, Jiangtao Lin, Yi Dong et al. · 2024 · Science China Materials
  67. Enhancing Tumor Immunity with IL-12 and PD-1 Blockade: A Strategy for Inducing Robust Central Memory T Cell Responses in Resistant Cancer Model
    Fentian Chen, Kaiqin Wu, Shiqi Lin, Jiaxing Cui, Xiaoqing Chen, Zhiren Zeng, Na Yuan, Mujin Fang, Xue Liu, Yuanzhi Chen et al. · 2024 · Antibodies
  68. LRP4 mutations promote tumor progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinoma
    Rongqi Sun, Kaixuan Liu, Si-Yuan Pan, Yuhang Ye, Ning Li, Shuangyi Chen, Xinyi Cui, Yuxi Zhang, Long Fei Chen, Jingyue Pan et al. · 2024 · Hepatology
  69. A lipid starvation strategy-synergized neutrophil activation for postoperative melanoma immunotherapy
    Hongjuan Zhao, Mengya Niu, Yuxin Guo, Xiu‐Qing Li, Yinke Wang, Qianqian Jiang, Qingling Song, Yi Zhang, Lei Wang · 2025 · Journal of Controlled Release
  70. Membrane Encapsulated Fe3O4@MnO@cGAMP Nanocatalyst for Cancer Therapy: cGAS‐STING Immune Pathway Activation
    Hua Chai, Renpeng Xia, Nan Ouyang, Jingyu Yao, Jiukun Hu, Minxuan Sun, Peng Miao · 2025 · Advanced Healthcare Materials
  71. Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination
    David Repáraz, Marta Ruiz, Leyre Silva, Belén Aparicio, Josune Egea, Elizabeth Guruceaga, Daniel Ajona, Yaiza Senent, Enrique Conde, Flor C. Navarro et al. · 2022 · Frontiers in Immunology
  72. Real-world clinical outcomes of nivolumab and taxane as a second- or later-line therapy for recurrent or unresectable advanced esophageal squamous cell carcinoma
    Manato Ohsawa, Yoichi Hamai, Manabu Emi, Yuta Ibuki, Tomoaki Kurokawa, Toru Yoshikawa, Ryosuke Hirohata, Nao Kitasaki, Morihito Okada · 2023 · Frontiers in Oncology
  73. Roles of Fascin in Dendritic Cells
    Hao-Jie Wang, Ya-Ping Jiang, Jun-Ying Zhang, Xiaoqi Tang, Jian-Shu Lou, Xin‐Yun Huang · 2023 · Cancers
  74. Multiple TMA-aided CRISPR/Cas13a platform for highly sensitive detection of IL-15 to predict immunotherapeutic response in nasopharyngeal carcinoma
    Yaxian Wu, Shan Xing, Yu Wang, Boyu Tian, Meng Yin Wu, Xueping Wang, Qi Huang, Xia He, Shulin Chen, Xiaohui Li et al. · 2023 · Journal for ImmunoTherapy of Cancer
  75. Human Microbial Transplant Restores T Cell Cytotoxicity and Anti-Tumor Response to PD-L1 Blockade in Gnotobiotic Mice
    Joshua N. Borgerding, Joan Shang, Graham J. Britton, Hélène Salmon, Camille Bigenwald, Barbara Maier, Samuel R. Rose, Ilaria Mogno, Alice Oliffson Kamphorst, Miriam Mérad et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  76. Microbial cancer immunotherapy reprograms hematopoiesis to enhance anti-tumor immunity
    Andrew W. Daman, Anthony C. Antonelli, Gil Redelman‐Sidi, Lucinda Paddock, Jin‐Gyu Cheong, Leonardo F. Jurado, Anna Binyamin, Song Jiang, Dughan J. Ahimovic, Shireen Khayat et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Prognostic Impact of Acute and Chronic Inflammatory Interleukin Signatures in the Tumor Microenvironment of Early Breast Cancer
    Anne-Sophie Heimes, Ina Shehaj, Katrin Almstedt, Slavomir Krajnak, Roxana Michaela Schwab, Kathrin Stewen, Antje Lebrecht, Walburgis Brenner, Annette Hasenburg, Marcus Schmidt · 2024 · International Journal of Molecular Sciences
  78. Emerging insights into intravital imaging, unraveling its role in cancer immunotherapy
    Minfeng Yang, Shiqiang Hou, Yao Chen, Hongzhao Chen, Minjie Chu, Songbai Liu · 2025 · Cancer Immunology Immunotherapy
  79. Neoantigen identification and TCR-T therapy development for solid tumors: current advances and future perspectives
    Xinyao Zheng, Yahui Zhao, Zhihua Liu · 2025 · Journal of the National Cancer Center
  80. Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling
    Carlos Oscar Ontiveros, Myrna G Garcia, Clare Murray, Yilun Deng, Haiyan Bai, Christopher Tanner, Bernice Leung, Xin Li, Alvaro Souto Padron, Ryan Michael Reyes et al. · 2025 · Nature Communications
  81. Programmed Cell Death Protein 1 Engagement Impairs Cytoskeletal Forces and Nuclear Mechanotransduction in T Cells
    Lingzhu Zhao, Guoqing Zhao, Jiaxin Fu, Yan Liu, Jinteng Feng, Guangjian Zhang, Feng Hua Xu, Hui Guo, Min Lin · 2025 · ACS Nano
  82. Ferroptosis-induced immune modulation: a new frontier in glioblastoma therapy
    Shaik Rahaman, Divya Vohora, Ähmed Kamal · 2026 · Naunyn-Schmiedeberg s Archives of Pharmacology
  83. miRNome targeting NF-κB signaling orchestrates macrophage-triggered cancer metastasis and recurrence
    Dong‐Ping Chen, Juncheng Wang, Zhengyu Liu, Pei-Lin Li, Ka‐Wo Chan, Xiang-Ning Wu, Wudexin Yao, Tingting Yao, Dong‐Ming Kuang, Wei Yuan · 2024 · Molecular Therapy
  84. Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer
    Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Ya‐Nan Jin, Zhenchong Xiong, Liangping Xia · 2024 · British Journal of Cancer
  85. Guidelines for preparation and flow cytometry analysis of human nonlymphoid tissue DC
    Diana Dudziak, Lukas Heger, William W. Agace, Joyce Bakker, Tanja D. de Gruijl, Regine J. Dress, Charles‐Antoine Dutertre, Thomas M. Fenton, Marieke F. Fransen, Florent Ginhoux et al. · 2024 · European Journal of Immunology
  86. Immunometabolism of Innate Immune Cells in Gastrointestinal Cancer
    Izabela Siemińska, Marzena Lenart · 2025 · Cancers
  87. Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
    Tingting Qin, Shiting Li, Leanne E. Henry, Elysia Chou, Raymond G. Cavalcante, Bailey Fabiny Garb, Nisha J. D’Silva, Laura S. Rozek, Maureen A. Sartor · 2023 · Cancer Research Communications
  88. Ag85B-ENO146-82 therapeutic vaccines enhance anti-tumor immunity by inducing CD8+ T cells and remodeling tumor microenvironment
    Fengjun Liu, Huan Huang, Xiaoli Yang, Shasha Jiang, Aotian Xu, Zhongjie Yu, Jun Li, Meng Yu, Yunyang Wang, Bin Wang · 2024 · International Immunopharmacology
  89. IL-2/anti-IL-2 antibody complexes augment immune responses to therapeutic cancer vaccines
    Miguel C. Sobral, Laura Cabizzosu, Shawn J. Kang, Kyle T Ruark, Alexander J. Najibi, Ryan S. Lane, Einat B. Vitner, Hamza Ijaz, Maxence O. Dellacherie, Mason T. Dacus et al. · 2024 · Proceedings of the National Academy of Sciences
  90. Exogenous signaling repairs defective T cell signaling inside the tumor microenvironment for better immunity
    Casey Moore, Joonbeom Bae, Longchao Liu, Huiyu Li, Yang‐Xin Fu, Jian Qiao · 2022 · JCI Insight
  91. A single-beam of light priming the immune responses and boosting cancer photoimmunotherapy
    Yue Ling Sun, Ruyin Han, Jiangyue Wang, Yang Qin, Ziwei Ren, Xiaolan Feng, Quanhong Liu, Xiaobing Wang · 2022 · Journal of Controlled Release
  92. A mouse model-based screening platform for the identification of immune activating compounds such as natural products for novel cancer immunotherapies
    Lisa Richter, Sonja Kropp, Peter Proksch, Stefanie Scheu · 2019 · Bioorganic & Medicinal Chemistry
  93. Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
    Riccardo Dolcetti, Alejandro López‐Soto, Jessica Dal Col · 2020 · Frontiers in Immunology
  94. Pembrolizumab and Ipilimumab as Second-Line Therapy for Advanced Melanoma
    Laura A. Huppert, ADIL I. DAUD · 2021 · Journal of Clinical Oncology
  95. Neutrophil regulation of immunotherapy for cancer is controlled by type II interferon
    Shengduo Pei, Yueyun Pan, Heng Liang, Li Lei, Qirong Lin, Jiarui Mi, Jeffrey V. Ravetch, Oliver Soehnlein, Mikael C. I. Karlsson · 2026 · Immunity
  96. Dendritic cell-targeted liposomes for cancer immunotherapy via inhibition of aryl hydrocarbon receptor
    Chen-Guang Zhang, Chen-Yun Yeh, Sheng-Yun Hsu, Mridula Prakash, Adrian B. Abarientos, Hsi-Ming Chiang-Hsieh, You‐Yu Lin, Christopher Llynard D. Ortiz, Lee‐Wei Yang, Pi‐Hui Liang et al. · 2025 · Journal of Nanobiotechnology
  97. Dual-sensitization nanoformulation combining glutamine metabolism inhibition and Fas/FasL activation for enhanced colorectal cancer immunotherapy
    Dan Yan, Wenzhe Yi, Ting Wu, Shuangshuang Hu, Yan Ding, Xindi Qian, Zhiwen Zhao, Dangge Wang, Huae Xu, Ying Cai et al. · 2025 · Journal of Controlled Release
  98. Targeting tumor-draining lymph node to overcome resistance to cancer immunotherapy: an update
    Jianan Lu, Jiangnan Yu, Tao Xu, Yina Li, Shuxian Chen, Qian Zhou, Lei Wang · 2025 · Cancer Drug Resistance
  99. Reframing adjuvant immunotherapy in melanoma: all of it starts with priming
    Paolo A. Ascierto, Ignacio Melero · 2025 · Journal for ImmunoTherapy of Cancer
  100. From Cell Death and Activation to Paralysis: Dysregulated Conventional Dendritic Cells in SIRS , Sepsis and Major Trauma Promote Immunosuppression
    Mitra Ashayeripanah, Antoine Roquilly, Jóse A. Villadangos · 2026 · Immunological Reviews